322 related articles for article (PubMed ID: 30317547)
1. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
[TBL] [Abstract][Full Text] [Related]
2. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
[No Abstract] [Full Text] [Related]
3. Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
Williams CP; Kenzik KM; Azuero A; Williams GR; Pisu M; Halilova KI; Ingram SA; Yagnik SK; Forero A; Bhatia S; Rocque GB
Oncologist; 2019 Jan; 24(1):31-37. PubMed ID: 30120157
[TBL] [Abstract][Full Text] [Related]
4. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
5. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
Vyas AM; Aroke H; Kogut S
J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
[TBL] [Abstract][Full Text] [Related]
6. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
[TBL] [Abstract][Full Text] [Related]
7. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
[TBL] [Abstract][Full Text] [Related]
8. Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.
Vyas A; Mantaian T; Kamat S; Kurian S; Kogut S
J Geriatr Oncol; 2021 Sep; 12(7):1092-1099. PubMed ID: 34099411
[TBL] [Abstract][Full Text] [Related]
9. Guideline Discordance and Patient Cost Responsibility in Medicare Beneficiaries With Metastatic Breast Cancer.
Williams CP; Azuero A; Kenzik KM; Pisu M; Nipp RD; Bhatia S; Rocque GB
J Natl Compr Canc Netw; 2019 Oct; 17(10):1221-1228. PubMed ID: 31590153
[TBL] [Abstract][Full Text] [Related]
10. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
[TBL] [Abstract][Full Text] [Related]
11. Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.
Hao Y; Li N; Fang AP; Koo V; Peeples M; Kageleiry A; Wu EQ; Guérin A
Adv Ther; 2016 Jun; 33(6):983-97. PubMed ID: 27216253
[TBL] [Abstract][Full Text] [Related]
12. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
13. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
[No Abstract] [Full Text] [Related]
14. Racial differences in outcomes for patients with metastatic breast cancer by disease subtype.
Vaz-Luis I; Lin NU; Keating NL; Barry WT; Lii H; Winer EP; Freedman RA
Breast Cancer Res Treat; 2015 Jun; 151(3):697-707. PubMed ID: 26022349
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
16. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
17. Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.
Hershman DL; Till C; Wright JD; Accordino M; Vaidya R; Barlow WE; Ramsey S; Unger JM
Breast Cancer Res Treat; 2020 Jun; 181(2):455-463. PubMed ID: 32306168
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer.
Paulsson AK; Fowble B; Lazar AA; Park C; Sherertz T
Clin Breast Cancer; 2020 Apr; 20(2):168-173. PubMed ID: 31744755
[TBL] [Abstract][Full Text] [Related]
19. ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study.
DaCosta Byfield S; Buck PO; Blauer-Peterson C; Poston SA; DaCosta Byfield S; Buck PO; Blauer-Peterson C; Poston SA
J Oncol Pract; 2016 Feb; 12(2):159-67. PubMed ID: 26395563
[TBL] [Abstract][Full Text] [Related]
20. The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer.
Laliberte L; Fennell ML; Papandonatos G
Med Care; 2005 May; 43(5):471-9. PubMed ID: 15838412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
